Article Information
History
- August 16, 2021.
Article Versions
- Version 1 (July 1, 2021 - 02:19).
- Version 2 (July 6, 2021 - 13:48).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicholas Bussière1,
- Jie Mei, PhD1,
- Cindy Lévesque-Boissonneault, MSc1,
- Mathieu Blais, PhD2,3,
- Sara Carazo, MD, PhD4,
- Francois Gros-Louis, PhD2,3,
- Gaston De Serres, MD, PhD4,
- Nicolas Dupré, MD, MSc, FRCP FAAN5,6 and
- Johannes Frasnelli, MD1,*
- 1Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada
- 2Axe Médecine régénératrice, CHU de Québec–Université Laval, Québec City, QC, Canada
- 3Faculty of Medicine, Department of Surgery, Université Laval, Québec City, QC, Canada
- 4Institut National de Santé Publique du Québec, Québec City, QC, Canada
- 5Faculty of Medicine, Department of Medicine, Université Laval, Québec City, QC, Canada
- 6Axe Neurosciences, CHU de Québec–Université Laval, Québec City, QC, Canada
- ↵*Correspondence to be sent to:
Johannes Frasnelli MD, Université du Québec à Trois-Rivières, 3351, boul. des Forges, C.P. 500, Trois-Rivières, QC G9A 5H7 Canada, Email: johannes.a.frasnelli{at}uqtr.ca
Posted August 16, 2021.
Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers
